{"transactions":[{"id":697764,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":26795,"kind":"person","name":"Yanez Michelle","position":1,"cik":"0001958023","reported_name":"Yanez Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-04T16:19:04.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2025 Equity Incentive Plan, subject to shareholder approval."}],"balance_after":1221271,"source":{"system":"sec-edgar","filing":"0001493152-26-035955","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000149315226035955/ownership.xml","form_type":"4"}},{"id":1176942,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":26795,"kind":"person","name":"Yanez Michelle","position":1,"cik":"0001958023","reported_name":"Yanez Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-07T21:25:09.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan."}],"balance_after":896271,"source":{"system":"sec-edgar","filing":"0001641172-25-003033","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000164117225003033/ownership.xml","form_type":"4"}},{"id":1261181,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":26795,"kind":"person","name":"Yanez Michelle","position":1,"cik":"0001958023","reported_name":"Yanez Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-20T02:27:39.000Z","date":"2024-12-02","kind":"gift","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1146271,"source":{"system":"sec-edgar","filing":"0001493152-25-007626","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000149315225007626/ownership.xml","form_type":"5"}},{"id":1336678,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":26795,"kind":"person","name":"Yanez Michelle","position":1,"cik":"0001958023","reported_name":"Yanez Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2024-12-10T22:15:37.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on December 6, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued to the Reporting Person on December 6, 2024 (the \"Grant Date\"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the \"Plan\"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents 150,000 stock options that were issued to the Reporting Person on December 6, 2024, that vest in equal halves on the six- and 12-month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $1.19 each."}],"balance_after":150000,"derivative":{"exercise_price":1.19,"expiration_date":"2034-12-09","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-24-049508","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224049508/ownership.xml","form_type":"4"}},{"id":1414990,"issuer":{"id":6962,"kind":"organization","name":"Telomir Pharmaceuticals, Inc."},"owners":[{"id":26795,"kind":"person","name":"Yanez Michelle","position":1,"cik":"0001958023","reported_name":"Yanez Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Incentive Stock Options (right to buy)","published_at":"2024-09-04T17:37:18.000Z","date":"2024-08-27","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 26, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the \"Plan\"). 50,000 stock options of such grant shall vest, respectively, on each of February 26, 2025, August 26, 2025, February 26, 2026 and August 26, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the \"Plan\"). 50,000 stock options of such grant shall vest, respectively, on each of February 26, 2025, August 26, 2025, February 26, 2026 and August 26, 2026."}],"balance_after":200000,"derivative":{"exercise_price":5.02,"expiration_date":"2034-08-27","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-24-034962","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1958023/000149315224034962/ownership.xml","form_type":"4"}},{"id":1514710,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":26795,"kind":"person","name":"Yanez Michelle","position":1,"cik":"0001958023","reported_name":"Yanez Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-16T17:34:39.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan."}],"balance_after":896271,"source":{"system":"sec-edgar","filing":"0001493152-24-020171","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000149315224020171/ownership.xml","form_type":"4"}},{"id":1559123,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":26795,"kind":"person","name":"Yanez Michelle","position":1,"cik":"0001958023","reported_name":"Yanez Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-03-27T21:53:43.000Z","date":"2024-03-26","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on March 26, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted under the Issuer's 2022 Amended and Restated Omnibus Incentive Plan (the \"Plan\") whereby 50% of such incentive options, or 75,000 options, will vest on the six month anniversary of the of the grant, or September 26, 2024, and the remaining 50% will vest on the first anniversary of the grant date, March 26, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents (i) 3,334 stock options that were issued to the Reporting Person under the Plan that became exercisable on June 15, 2022 at an exercise price of $5.00 (ii) 3,333 stock options that were issued to the Reporting Person under the Plan that became exercise on June 15, 2023 at an exercise price of $5.00 each, (iii) 15,566 stock options were issued to the Reporting Person on April 28, 2023, pursuant to a grant under the Issuer's Plan which vested in full on April 28, 2024 at an exercise price of $6.50 each, (iv) 15,566 stock options were issued to the Reporting Person on April 28, 2023, pursuant to a grant under the Issuer's Plan which will vest in full on April 28, 2024 at an exercise price of $6.50 each (v) 20,000 stock options were issued to the Reporting Person on August 17, 2023, pursuant to a grant under the Issuer's Plan which vested in full on August 17, 2023 at an exercise price of $6.50 each."}],"balance_after":57799,"derivative":{"exercise_price":1.15,"expiration_date":"2034-03-26","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-24-011574","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224011574/ownership.xml","form_type":"4"}},{"id":1800359,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":26795,"kind":"person","name":"Yanez Michelle","position":1,"cik":"0001958023","reported_name":"Yanez Michelle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary and Treasurer"}}],"security":"Stock Options","published_at":"2023-08-21T22:00:17.000Z","date":"2023-08-17","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued to the Reporting Person on August 17,2023, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. The award vested in full on August 17, 2023."}],"balance_after":20000,"derivative":{"exercise_price":6.5,"expiration_date":"2033-08-17","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-23-029735","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315223029735/ownership.xml","form_type":"4"}},{"id":1889763,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":26795,"kind":"person","name":"Yanez Michelle","position":1,"cik":"0001958023","reported_name":"Yanez Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T23:09:26.000Z","date":"2023-05-05","kind":"other","planned":false,"acquired":true,"shares":796271,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock of Inhibitor Therapeutics, Inc. were distributed to the members of Hedgepath, LLC (\"HPLLC\"), pro-rata pursuant to their membership interest in HPLLC."}],"balance_after":800673,"source":{"system":"sec-edgar","filing":"0000899243-23-013195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000089924323013195/doc4.xml","form_type":"4"}}]}